Market Tracker

04/24 7:04am ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

116.70
Delayed Data
As of Apr 21
 -0.56 / -0.48%
Today’s Change
71.46
Today|||52-Week Range
117.99
+58.41%
Year-to-Date

Today’s Trading

Previous close117.26
Today’s open117.17
Day’s range115.92 - 117.69
Volume2,803,925
Average volume (3 months)1,875,130
Market cap$29.0B
Dividend yield--
Data as of 04/21/2017

Growth & Valuation

Earnings growth (last year)+80.09%
Earnings growth (this year)+87.21%
Earnings growth (next 5 years)+68.70%
Revenue growth (last year)+64.89%
P/E ratioNM
Price/Sales10.59
Price/Book25.05

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.01-0.02%
ZTSZoetis Inc-0.10-0.18%
ALXNAlexion Pharmaceutic...-1.90-1.60%
INCYIncyte Corp-0.10-0.08%
Data as of 04/21/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$0.31
Annual revenue (last year)$1.7B
Annual profit (last year)-$112.1M
Net profit margin-6.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
EVP, Chief Operating &
Financial Officer
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts